Author

L. Da

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

K. Song· 2 shared Y. Shi· 2 shared B.-T. Li· 1 shared C. Jiang· 1 shared D. Yin· 1 shared F. Dong· 1 shared H. Jiang· 1 shared H. Xu· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Song

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1

F. Dong, K. He, S. Zhang, K. Song, L. Jiang, L. Hu, Q. Li, X.-L. Zhang, N. Zhang, B.-T. Li, L.-L. Zhu, J. Li, M. Feng, Y. Gao, J. Chen, , S.-H. Jiang

This study identifies GLUT1 as a target of SSRIs, showing citalopram inhibits HCC by reversing the Warburg effect through GLUT1 antagonism.

Cell Reports · Oct 1, 2024Peer-reviewedCancer Biology

Discovering SARS-CoV-2 neoepitopes and the associated TCR-pMHC recognition mechanisms by combining single-cell sequencing, deep learning, and molecular dynamics simulation techniques

K. Song, H. Xu, Y. Shi, J. Hao, L. Da, X. Zou

This study identifies SARS-CoV-2 epitopes and their TCR recognition mechanisms using single-cell sequencing, deep learning, and molecular dynamics simulations.

bioRxiv · Feb 2, 2023 · PreprintImmunology

A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities

Y. Cai, D. Yin, S. Ling, X. Tian, Y. Li, Z. Xu, H. Jiang, X. Zhang, X. Wang, Y. Shi, Y. Zhang, L. Da, S.-c. Tao, Q. Wang, J. Xu, , J. Hong

This study develops a SARS-CoV-2 vaccine candidate using virus simulating particles that induces strong neutralizing immune responses with a single dose.

bioRxiv · May 14, 2020 · PreprintBioengineering